70
Participants
Start Date
April 17, 2018
Primary Completion Date
June 21, 2019
Study Completion Date
June 21, 2019
SYNB1618
SYNB1618 is supplied in a buffered solution in 5 mL polypropylene cryovials with a nominal 5 mL fill volume, administered with 100 mL of masking buffer solution.
Placebo
Subjects receive placebo orally in a chilled buffered solution (100 mL).
Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Vanderbilt University Medical Center, Nashville
PRA Health Sciences, Salt Lake City
Boston Children's Hospital, Boston
Lead Sponsor
Synlogic
INDUSTRY